ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669145 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669145; 2) Community: the network communities that were significantly associated with the response to NSC 669145; 3) Molecule: the relationships between components within communities and NSC 669145; 4) MDR: the compounds that were significantly associated with the NSC 669145.

NSC Compound Enrichment Correlation
NSC 316158 Null 0.0273093708703114 0.21099184
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0273093708703114 0.55184994
NSC 356885 Leucinostatin A (9CI) 0.0273093708703114 -0.011819609
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0273093708703114 0.72917021
NSC 363812 Tetraplatin 0.0273093708703114 0.5624274
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0273093708703114 0.69515178
NSC 38643 Lenamycin 0.0273093708703114 0.52148673
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0273093708703114 0.66202466
NSC 621336 Null 0.0273093708703114 0.52566061
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0273093708703114 0.51106308
Total:86  Current:57    [First] [Prev] [Next] [Last]